key: cord-0951763-iualbmwm
authors: Naramala, Srikanth; Konala, Venu Madhav; Adapa, Sreedhar; Chenna, Avantika; Garlapati, Pavani Reddy; Gayam, Vijay
title: Response to Letter Regarding “A Case Series of Patients Coinfected With Influenza and COVID-19”
date: 2020-10-05
journal: J Investig Med High Impact Case Rep
DOI: 10.1177/2324709620963611
sha: 0ef51fd361d53e65eb7528685c780a61cc0afe0c
doc_id: 951763
cord_uid: iualbmwm

nan

Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

To the Editor, We want to sincerely appreciate Suwanwongse and Shabarek 1 for investing their precious time to read the article "A Case Series of Patients Coinfected With Influenza and COVID-19" with keen observation and giving an unbiased opinion. Suwanwongse and Shabarek also provided sound reasoning and cited appropriate literature backing up their point. We agree with Suwanwongse and Shabarek's theoretical reasoning of influenza coinfection, worsening an inflammatory cascade. We also agree on the point of upregulation of interferons with viral infections like influenza 2 and the citing of literature related to interferon-driven upregulation of ACE2, which is the key receptor for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) to enter the human host cells. 3 The authors' concern about the statement "the coinfection did not significantly worsen the symptoms or outcomes," stating it is premature, is apt and justified from the points mentioned above. Finally, we agree with the authors' comments until future studies show any surprising outcomes. The impact of coinfection of both influenza and COVID-19 (coronavirus disease-2019) on clinical outcomes is unknown at this point. Physicians should be mindful that a positive influenza test does not rule out the possibility of simultaneous COVID-19 disease and vice versa. 

Can coinfection with influenza worsen COVID-19 outcomes?

Influenza virus activation of the interferon system

SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues

963611H ICXXX10.1177/2324709620963611Journal of Investigative Medicine High Impact Case ReportsNaramala et al research-article20202020